# RNADerm Therapeutics, Inc. — Form D

RNADerm Therapeutics, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-15. The offering totals $14.8M, of which $750K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-03-15
- Form: D
- Accession: 0001770512-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.8M
- Amount sold: $750K
- Remaining: $14.0M
- Investors: 3
- Date of first sale: 2019-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-334973

## Issuer

- Name: RNADerm Therapeutics, Inc.
- CIK: 0001770512
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2600 TENTH STREET, #435, BERKELEY, CA, 94710
- Phone: 857-222-4653

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Mark de Souza | Director | Hingham, MA |
| Aaron K Sato | Director | Berkeley, CA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Aaron K Sato | Executive Officer | Berkeley, CA |

## More

- [CIK 1770512 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1770512&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001770512-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.